Tamoxifen for the prevention of breast cancer -: Pro

被引：24

作者：

Fisher, B ^{[1
]}

机构：

[1] Natl Surg Adjuvant Breast & Bowel Project, Pittsburgh, PA 15212 USA

来源：

EUROPEAN JOURNAL OF CANCER | 2000年 / 36卷 / 02期

关键词：

D O I：

10.1016/S0959-8049(99)00269-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：142 / 145

页数：4

共 17 条

[1] American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: Tamoxifen and raloxifene [J].

Chlebowski, RT ;

Collyar, DE ;

Somerfield, MR ;

Pfister, DG .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) :1939-1955

[2] ADJUVANT CHEMOTHERAPY WITH AND WITHOUT TAMOXIFEN IN THE TREATMENT OF PRIMARY BREAST-CANCER - 5-YEAR RESULTS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT TRIAL [J].

FISHER, B ;

REDMOND, C ;

BROWN, A ;

FISHER, ER ;

WOLMARK, N ;

BOWMAN, D ;

PLOTKIN, D ;

WOLTER, J ;

BORNSTEIN, R ;

LEGAULTPOISSON, S ;

SAFFER, EA .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (04) :459-471

[3] Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].

Fisher, B ;

Costantino, JP ;

Wickerham, DL ;

Redmond, CK ;

Kavanah, M ;

Cronin, WM ;

Vogel, V ;

Robidoux, A ;

Dimitrov, N ;

Atkins, J ;

Daly, M ;

Wieand, S ;

Tan-Chiu, E ;

Ford, L ;

Wolmark, N .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388

[4] National surgical adjuvant breast and bowel project breast cancer prevention trial: A reflective commentary [J].

Fisher, B .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) :1632-1639

[5] Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors [J].

Fisher, B ;

Dignam, J ;

Bryant, J ;

DeCillis, A ;

Wickerham, DL ;

Wolmark, N ;

Costantino, J ;

Redmond, C ;

Fisher, ER ;

Bowman, DM ;

Deschenes, L ;

Dimitrov, NV ;

Margolese, RG ;

Robidoux, A ;

Shibata, H ;

Terz, J ;

Paterson, AHG ;

Feldman, MI ;

Farrar, W ;

Evans, J ;

Lickley, HL .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (21) :1529-1542

[6] A RANDOMIZED CLINICAL-TRIAL EVALUATING TAMOXIFEN IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR POSITIVE TUMORS [J].

FISHER, B ;

COSTANTINO, J ;

REDMOND, C ;

POISSON, R ;

BOWMAN, D ;

COUTURE, J ;

DIMITROV, NV ;

WOLMARK, N ;

WICKERHAM, DL ;

FISHER, ER ;

MARGOLESE, R ;

ROBIDOUX, A ;

SHIBATA, H ;

TERZ, J ;

PATERSON, AHG ;

FELDMAN, MI ;

FARRAR, W ;

EVANS, J ;

LICKLEY, HL ;

KETNER, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :479-484

[7]

Fisher D, 1997, ARACHNE, V4, P78

[8] PROJECTING INDIVIDUALIZED PROBABILITIES OF DEVELOPING BREAST-CANCER FOR WHITE FEMALES WHO ARE BEING EXAMINED ANNUALLY [J].

GAIL, MH ;

BRINTON, LA ;

BYAR, DP ;

CORLE, DK ;

GREEN, SB ;

SCHAIRER, C ;

MULVIHILL, JJ .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (24) :1879-1886

[9] EFFECT OF TAMOXIFEN (ICI 46,474) ON INITIATION AND GROWTH OF DMBA - INDUCED RAT MAMMARY CARCINOMATA [J].

JORDAN, VC .

EUROPEAN JOURNAL OF CANCER, 1976, 12 (06) :419-424

[10] TAMOXIFEN - USE IN TREATMENT OF METASTATIC BREAST-CANCER REFRACTORY TO COMBINATION CHEMOTHERAPY [J].

LEGHA, SS ;

BUZDAR, AU ;

HORTOBAGYI, GN ;

WISEMAN, C ;

BENJAMIN, RS ;

BLUMENSCHEIN, GR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 242 (01) :49-52

← 1 2 →